IL325937A - נוגדנים המועברים על ידי aav ושיטות לשימוש בהם - Google Patents
נוגדנים המועברים על ידי aav ושיטות לשימוש בהםInfo
- Publication number
- IL325937A IL325937A IL325937A IL32593726A IL325937A IL 325937 A IL325937 A IL 325937A IL 325937 A IL325937 A IL 325937A IL 32593726 A IL32593726 A IL 32593726A IL 325937 A IL325937 A IL 325937A
- Authority
- IL
- Israel
- Prior art keywords
- aav
- methods
- delivered antibodies
- antibodies
- delivered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363515218P | 2023-07-24 | 2023-07-24 | |
| PCT/US2024/039323 WO2025024541A2 (en) | 2023-07-24 | 2024-07-24 | Aav-delivered antibodies and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325937A true IL325937A (he) | 2026-03-01 |
Family
ID=94375705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325937A IL325937A (he) | 2023-07-24 | 2024-07-24 | נוגדנים המועברים על ידי aav ושיטות לשימוש בהם |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL325937A (he) |
| WO (1) | WO2025024541A2 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10350245B2 (en) * | 2015-01-21 | 2019-07-16 | Fred Hutchinson Cancer Research Center | Point-of-care and/or portable platform for gene therapy |
| WO2020097252A1 (en) * | 2018-11-06 | 2020-05-14 | University Of Miami | Compositions and production of recombinant aav viral vectors capable of glycoengineering in vivo |
| WO2020221450A1 (en) * | 2019-04-30 | 2020-11-05 | Humabs Biomed Sa | Antibodies and methods for treatment of influenza a infection |
| CN119173251A (zh) * | 2022-04-29 | 2024-12-20 | 库尔制药开发公司 | 用于克服治疗性载体和蛋白质的免疫原性的耐受性免疫修饰纳米粒子 |
-
2024
- 2024-07-24 IL IL325937A patent/IL325937A/he unknown
- 2024-07-24 WO PCT/US2024/039323 patent/WO2025024541A2/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025024541A3 (en) | 2025-04-17 |
| WO2025024541A2 (en) | 2025-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019709D0 (en) | Anti-Coronavirus antibodies and methods of use | |
| IL316368A (he) | נוגדנים אנטי- tl1a ושיטות לשימוש בהם | |
| SMT202500106T1 (it) | Anticorpi anti-par-2 e loro metodi d'uso | |
| IL315845A (he) | נוגדנים אנטי-דקטין-1 ושיטות לשימוש בהם | |
| IL298668B1 (he) | נוגדנים נגד cd200r1 ושיטות לשימוש בהם | |
| IL319590A (he) | נוגדנים רב-ספציפיים ושיטות לשימוש בהם | |
| IL316065A (he) | נוגדנים אנטי- cd28ושיטות לשימוש בהם | |
| IL317690A (he) | נוגדנים אנטי- gpnmbושיטות לשימוש בהם | |
| IL318694A (he) | נוגדנים כנגד ccr8 ושיטות לשימוש בהם | |
| IL308260A (he) | נוגדנים נגד טיגיט ודרכי השימוש בהם | |
| IL325937A (he) | נוגדנים המועברים על ידי aav ושיטות לשימוש בהם | |
| IL318357A (he) | נוגדני anti-il27r ושיטות השימוש בהם | |
| IL316700A (he) | נוגדני anti-bmp9 ושיטות השימוש בהם | |
| IL316894A (he) | נוגדני anti-tnfr2 ושיטות השימוש בהם | |
| IL321679A (he) | נוגדני אנטי-ror2 ושיטות לשימוש | |
| IL310551A (he) | נוגדנים חד-שבטיים ספציפיים ל-osmr ושיטות השימוש בהם | |
| IL311003A (he) | נוגדנים אנטי-2her ושיטות שימוש בהם | |
| IL325840A (he) | נוגדני pd-l1xcd28 דו-ספציפיים ושיטות שימוש בהם | |
| IL325837A (he) | נוגדני pd-l1x4-1bb דו-ספציפיים ושיטות שימוש בהם | |
| GB202204813D0 (en) | Human monoclonal antibodies and methods of use thereof | |
| GB202204736D0 (en) | Human monoclonal antibodies and methods of use thereof | |
| CA3303930A1 (en) | Anti-nectin-4 antibodies and methods of use thereof | |
| CA3298139A1 (en) | Aav-delivered antibodies and methods of use thereof | |
| CA3292076A1 (en) | Anti-toh1 antibodies and methods of use thereof | |
| CA3286084A1 (en) | Anti-cd161 antibodies and methods of use thereof |